BENSALEM, Pa., July 23, 2021 /PRNewswire/ -- Law Offices of Howard G.
Former penny stocks biotech analysts are bullish on right now. The post 3 Former Penny Stocks With Bullish Analysts & Price Targets Up To 120% appeared first on Penny Stocks to Buy, Picks, News and In
It would likely take until mid-2023 for the FDA to approve Covaxin. By that time, the shot could be obsolete.
New York, New York--(Newsfile Corp. - July 22, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Oc
New York, New York--(Newsfile Corp. - July 20, 2021) -  The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Ocugen, Inc. (NASDAQ: OCGN) alleging tha
New York, New York--(Newsfile Corp. - July 20, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. (NASDAQ: OCGN) between February 2, 2
New York, New York--(Newsfile Corp. - July 20, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Oc
Stocks for companies developing or already distributing a vaccine for covid are on the move Tuesday and we've got all the details. The post Covid Vaccine Stocks: Why NVAX, OCGN, MRNA and QDEL Are on t

Why Shares of Ocugen Climbed Today

05:33pm, Monday, 19'th Jul 2021
The delta variant is lifting the tide of companies associated with COVID testing and prevention.
New York, New York--(Newsfile Corp. - July 19, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Oc
NEW YORK, July 16, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN) and certain of its officers.
New York, New York--(Newsfile Corp. - July 16, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Ocugen, Inc. (NASDAQ: OCGEN).Sh
MALVERN, Pa., July 16, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc.  (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness dise
New York, New York--(Newsfile Corp. - July 16, 2021) - WHY: New York, N.Y., July 16, 2021. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. (NASD
New York, New York--(Newsfile Corp. - July 16, 2021) - To: All persons or entities who purchased or otherwise acquired securities of Ocugen, Inc. ("Ocugen") (NASDAQ: OCGN) between February 2, 2021 and
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE